News and Events
Genesis Biotechnology Group announces second year of CRO relationship with Yale University
Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.
Genesis Biotechnology Group announces partnership with Yale University
Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima
Dr. Michael S. McQueney is on the Organizing Committee of the 18th International Conference of the Inflammation Research Association, 2014, and is co-chairing a session on Immunity and Inflammation in Cancer. Dr. McQueney is on the Board of Directors of the Inflammation Research Association.
Dr. James Beasley to present at 2012 SLAS in Orlando, Florida.
VENENUM Biodesign exhibits at 2012 SLAS in San Diego.
VENENUM Biodesign Announces Opening of Medicinal Chemistry Labs Hamilton, NJ. June 22, 2011.
VENENUM Biodesign: Biotech Company Relocates to State of the Art Facility
Hamilton, NJ. Jan. 3, 2011
Biotech Company Releases New Web Presence
Hamilton, NJ. Dec. 21, 2010